NCT05963217 2025-07-02Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLUniversity Health Network, TorontoPhase 1 Recruiting19 enrolled
NCT04104776 2025-05-15A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasNovartisPhase 1/2 Recruiting275 enrolled
NCT06644443 2024-10-16BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple MyelomaShenzhen University General HospitalPhase 1/2 Recruiting10 enrolled
NCT04097067 2024-08-27ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-LymphomaUniversity Hospital MuensterPhase NA Recruiting83 enrolled
NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Recruiting36 enrolled